PBYI
PUMA BIOTECHNOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.54
−0.75%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.23x
- Debt / assets
- 0.02x
- Debt / EBITDA
- 0.11x
- Net debt / EBITDA
- -0.70x
Liquidity & coverage
- Current ratio
- 2.91x
- Quick ratio
- 2.64x
- Cash ratio
- 1.88x
- Interest coverage
- 8.65x
- EBITDA / interest
- 12.83x
- Working capital
- $95.2M
Cash & dividend
- FCF / debt
- 8.54x
- Cash flow / debt
- 8.54x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026